Esra Kardeş

Esra Kardeş

Auto-generated profile, based on publicly available information

Esra Kardeş

Umraniye Training and Research Hospital, University of Health Sciences

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2024 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
HAHilmi Altıntaş
Hilmi Altıntaş
EKEsra Kardeş
Esra Kardeş
To examine the demographic characteristics, findings and complication rates in patients with Behçet's uveitis (BU) and to investigate the effect of early biological therapy on the development of complications. Medical records of 94 patients with BU were retrospectively reviewed. Demographic data, ocular findings and complications at presentation, complications during follow-up, and treatments received during follow-up were analyzed. Patients who were followed for at least 24 months were divided into two groups according to the time of presentation as Group 1 (between 2009 and 2015) and Group 2 (between 2016 and 2021). Complications at the time of presentation and during follow-up, and treatments were compared. We enrolled 94 patients with a male-to-female ratio of 1.94 with a mean age of 30 ± 12 years. Median follow-up was 58.1(12-163) months. There were 35 patients (66 eyes) in Group 1 and 33 patients (61 eyes) in Group 2. At the time of presentation, end-stage disease, cataract, epiretinal membrane, and optic atrophy were significantly more common in Group 1 than in Group 2 (p < 0.05). A significantly higher proportion of eyes in Group 1 developed macular edema, cataract, epiretinal membrane, and macular atrophy during-follow-up (p < 0.05). Median time to initiation of biological treatment was 17.29 months in Group 1 and 3.33 months in Group 2 (p < 0.001). The overall complication rate was significantly lower in Group 2. Prognosis of BU is improved after the introduction of biological treatment. Early use of biological agents in BU is effective in decreasing sight-threatening ocular complications.

16 June 2026 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
SASeda Kutluğ Ağaçkiran
Seda Kutluğ Ağaçkiran
EKEsra Kardeş
Esra Kardeş
AAAbdulbaki̇ Ağaçkiran
Abdulbaki̇ Ağaçkiran
HDHaner Di̇rEskeneli̇
Haner Di̇rEskeneli̇
FAFatma Alibaz-Oner
Fatma Alibaz-Oner
Background/aim: Ocular involvement is a major cause of morbidity in Behçet’s disease (BD), and its diagnosis may be challenging, particularly for patients with isolated ocular manifestations or incomplete fulfillment of diagnostic criteria. Increased common femoral vein (CFV) wall thickness measured by Doppler ultrasonography (US) has previously been shown to be a sensitive and specific marker for systemic BD. This study aimed to evaluate whether CFV wall thickness measurement may serve as a supportive tool in distinguishing Behçet’s uveitis (BU) from other forms of inflammatory uveitis. Materials and methods: This retrospective study included 45 patients with BU fulfilling the International Study Group criteria for BD and 72 patients with non-BD uveitis of infectious and noninfectious etiologies. Bilateral CFV wall thickness was measured using color Doppler US by a radiologist blinded to the clinical data. Group comparisons were performed and multivariate linear regression analyses were used to assess whether BU was independently associated with increased CFV wall thickness after adjustment for potential confounders. Exploratory analyses additionally evaluated the effects of disease duration and systemic treatment status. Results: Mean CFV wall thickness was significantly higher in the BU group than in the non-BU group in both extremities (p < 0.001). BU remained an independent predictor of increased CFV wall thickness after adjustment for sex and venous Doppler findings. Additional exploratory analyses adjusting for disease duration and current systemic treatment status did not change this association. Conclusion: CFV wall thickness measured by Doppler US was significantly increased in patients with BU compared to other forms of inflammatory uveitis. These findings suggest that CFV wall thickness may serve as a supportive or adjunctive imaging marker in selected cases to assist in the differential diagnosis of ocular BD.